Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase ...

Orelabrutinib, a highly selective CNS-penetrant, oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor with best-in-class potential now ...
University of Denver

Faculty and Staff Grants From Summer 2025

May Faculty and Staff GrantsRestrictedCasey Myers, Ritchie School of Engineering & Computer ScienceFunder: RestrictedAbstract ...
The Malaysian Reserve

Union Home Mortgage Foundation Announces Third Quarter 2025 Grant Recipients

Awardees include 10 nonprofits in Arizona, Kentucky, Louisiana, Michigan, Ohio, North Carolina, and South Carolina STRONGSVILLE, Ohio, Oct. 7, 2025 ...
The Atlanta Voice

A discredited therapy for gay and trans youth is at the center of a Supreme Court case. Here’s what to know

The US Supreme Court will hear a case on the constitutionality of a Colorado law banning conversion therapy for minors. The ...